Literature DB >> 22203589

Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.

Andrés Pizzorno1, Yacine Abed, Xavier Bouhy, Edith Beaulieu, Corey Mallett, Rupert Russell, Guy Boivin.   

Abstract

Amino acid substitutions at residue I223 of the neuraminidase (NA) protein have been identified in 2009 pandemic influenza (pH1N1) variants with altered susceptibilities to NA inhibitors (NAIs). We used reverse genetics and site-directed mutagenesis to generate the recombinant A/Québec/144147/09 pH1N1 wild-type virus (WT) and five (I223R, I223V, H275Y, I223V-H275Y, and I223R-H275Y) NA mutants. A fluorimetry-based assay was used to determine 50% inhibitory concentrations (IC(50)s) of oseltamivir, zanamivir, and peramivir. Replicative capacity was analyzed by viral yield assays in ST6GalI-MDCK cells. Infectivity and transmission of the WT, H275Y, and I223V-H275Y recombinant viruses were evaluated in ferrets. As expected, the H275Y mutation conferred resistance to oseltamivir (982-fold) and peramivir (661-fold) compared to the drug-susceptible recombinant WT. The single I223R mutant was associated with reduced susceptibility to oseltamivir (53-fold), zanamivir (7-fold) and peramivir (10-fold), whereas the I223V virus had reduced susceptibility to oseltamivir (6-fold) only. Interestingly, enhanced levels of resistance to oseltamivir and peramivir and reduced susceptibility to zanamivir (1,647-, 17,347-, and 16-fold increases in IC(50)s, respectively) were observed for the I223R-H275Y recombinant, while the I223V-H275Y mutant exhibited 1,733-, 2,707-, and 2-fold increases in respective IC(50)s. The I223R and I223V changes were associated with equivalent or higher viral titers in vitro compared to the recombinant WT. Infectivity and transmissibility in ferrets were comparable between the recombinant WT and the H275Y or I223V-H275Y recombinants. In conclusion, amino acid changes at residue I223 may alter the NAI susceptibilities of pH1N1 variants without compromising fitness. Consequently, I223R and I223V mutations, alone or with H275Y, need to be thoroughly monitored.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203589      PMCID: PMC3294894          DOI: 10.1128/AAC.05994-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.

Authors:  Ha T Nguyen; Alicia M Fry; P Ann Loveless; Alexander I Klimov; Larisa V Gubareva
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

2.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

3.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

4.  Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.

Authors:  Erhard van der Vries; Foekje F Stelma; Charles A B Boucher
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

5.  Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.

Authors:  Shuji Hatakeyama; Yuko Sakai-Tagawa; Maki Kiso; Hideo Goto; Chiharu Kawakami; Keiko Mitamura; Norio Sugaya; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

7.  Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation.

Authors:  Yacine Abed; Philippe Simon; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

8.  The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant.

Authors:  Philippe Simon; Benjamin P Holder; Xavier Bouhy; Yacine Abed; Catherine A A Beauchemin; Guy Boivin
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

9.  Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

Authors:  Taronna R Maines; Akila Jayaraman; Jessica A Belser; Debra A Wadford; Claudia Pappas; Hui Zeng; Kortney M Gustin; Melissa B Pearce; Karthik Viswanathan; Zachary H Shriver; Rahul Raman; Nancy J Cox; Ram Sasisekharan; Jacqueline M Katz; Terrence M Tumpey
Journal:  Science       Date:  2009-07-02       Impact factor: 47.728

10.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

View more
  30 in total

1.  Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.

Authors:  Yacine Abed; Andrés Pizzorno; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.

Authors:  Mélanie Samson; Yacine Abed; François-Marc Desrochers; Stephanie Hamilton; Angela Luttick; Simon P Tucker; Melinda J Pryor; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

3.  Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets.

Authors:  Andrés Pizzorno; Yacine Abed; Chantal Rhéaume; Xavier Bouhy; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

Review 4.  Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models.

Authors:  Jessica A Belser; Alissa M Eckert; Terrence M Tumpey; Taronna R Maines
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-13       Impact factor: 11.056

Review 5.  Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.

Authors:  Elena A Govorkova
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

6.  Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.

Authors:  Andrés Pizzorno; Yacine Abed; Pier-Luc Plante; Julie Carbonneau; Mariana Baz; Marie-Ève Hamelin; Jacques Corbeil; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

7.  Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.

Authors:  Yun Hee Baek; Min-Suk Song; Eun-Young Lee; Young-il Kim; Eun-Ha Kim; Su-Jin Park; Kuk Jin Park; Hyeok-il Kwon; Philippe Noriel Q Pascua; Gyo-Jin Lim; Semi Kim; Sun-Woo Yoon; Myung Hee Kim; Richard J Webby; Young-Ki Choi
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

8.  Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards.

Authors:  Anna Gillman; Shaman Muradrasoli; Hanna Söderström; Fredrik Holmberg; Neus Latorre-Margalef; Conny Tolf; Jonas Waldenström; Gunnar Gunnarsson; Björn Olsen; Josef D Järhult
Journal:  Appl Environ Microbiol       Date:  2015-01-23       Impact factor: 4.792

Review 9.  Detection and management of antiviral resistance for influenza viruses.

Authors:  Guy Boivin
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

10.  A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance.

Authors:  Lan Huang; Yang Cao; Jianfang Zhou; Kun Qin; Wenfei Zhu; Yun Zhu; Lei Yang; Dayan Wang; Hong Wei; Yuelong Shu
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.